Oncology drugs are clearly the focus of development going into the future, while drugs for infectious disease and central nervous system also make up a large proportion of R&D spend.
Figure 1: Number of pipeline drugs in the US, by therapy area
Source: GlobalData, Pharma Intelligence Center, Drug Database [Accessed 1 November 2017]
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData